Anaveon

Anaveon is a clinical stage biopharmaceutical company that develops biologics to modulate the function of cytokines and provide substantial therapeutic benefit to cancer patients.

The company's vision is to develop novel immune therapies benefiting patients suffering from a wide variety of diseases with immune pathology.

Anaveon is focused on developing therapeutics that target central regulatory nodes of the immune system to selectively eliminate or reprogram pathogenic immune cells and restore durable immune balance.